Log In
BCIQ
Print this Print this
 

Killer cell immunoglobulin-like receptor two domains long cytoplasmic tail 1 (KIR2DL1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Killer cell immunoglobulin-like receptor two domains long cytoplasmic tail 1 (KIR2DL1)

BCIQ
Print ChartPrint this
1 1 1
Phases of DevelopmentPreclinicalPhase IPhase II
Cancer

1

1

1




 Products Targeting Killer cell immunoglobulin-like receptor two domains long cytoplasmic tail 1 (KIR2DL1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$465.0M

$35.0M

$430.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today